Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Liabilities and Shareholders Equity (2016 - 2018)

Historic Liabilities and Shareholders Equity for Sanofi (SNY) over the last 17 years, with Q3 2025 value amounting to $151.7 billion.

  • Sanofi's Liabilities and Shareholders Equity changed N/A to $151.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $573.8 billion, marking a year-over-year increase of 10805.98%. This contributed to the annual value of $141.9 billion for FY2024, which is 373.47% up from last year.
  • According to the latest figures from Q3 2025, Sanofi's Liabilities and Shareholders Equity is $151.7 billion.
  • In the past 5 years, Sanofi's Liabilities and Shareholders Equity registered a high of $151.7 billion during Q3 2025, and its lowest value of $129.3 billion during Q4 2022.
  • Its 5-year average for Liabilities and Shareholders Equity is $138.0 billion, with a median of $137.6 billion in 2021.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 710606.35% in 2021, then tumbled by 600.9% in 2022.
  • Sanofi's Liabilities and Shareholders Equity (Quarter) stood at $137.6 billion in 2021, then fell by 6.01% to $129.3 billion in 2022, then increased by 5.24% to $136.1 billion in 2023, then grew by 4.29% to $141.9 billion in 2024, then grew by 6.93% to $151.7 billion in 2025.
  • Its last three reported values are $151.7 billion in Q3 2025, $141.4 billion for Q2 2025, and $138.7 billion during Q1 2025.